A study to test different doses of BI 1831169 alone and in combination with an anti-PD-1 antibody in people with different types of advanced cancer (solid tumors).

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-512504-19-00

Acronym

1456-0001

Enrollment

122

Registered

2024-07-23

Start date

2025-05-28

Completion date

Unknown

Last updated

2025-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Belgium, France, Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026